Literature DB >> 22050253

A review of the methods, interpretation, and limitations of the urine drug screen.

E Claire Markway1, Stephanie N Baker.   

Abstract

Toxicology screens are used to detect the presence of prescription, nonprescription, or illicit substances. These tests are used in emergency situations to detect intentional or accidental overdose, to monitor drug dependency, and to screen for medical or legal purposes. An initial immunoassay reports qualitative results based on established cut-off concentrations. As a screening test, the initial immunoassay is less sensitive and therefore must be interpreted in the context of confounding variables such as the testing method, the substance being screened, and patient-specific characteristics. Either gas chromatography or high-performance liquid chromatography can be used to confirm positive results. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22050253     DOI: 10.3928/01477447-20110922-22

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  7 in total

1.  Probe Heating Method for the Analysis of Solid Samples Using a Portable Mass Spectrometer.

Authors:  Shun Kumano; Masuyuki Sugiyama; Masuyoshi Yamada; Kazushige Nishimura; Hideki Hasegawa; Hidetoshi Morokuma; Hiroyuki Inoue; Yuichiro Hashimoto
Journal:  Mass Spectrom (Tokyo)       Date:  2015-04-25

Review 2.  Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?

Authors:  Krishnan Chakravarthy; Aneesh Goel; George M Jeha; Alan David Kaye; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2021-02-17

3.  Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking.

Authors:  Donald M Dougherty; Tara E Karns; Jillian Mullen; Yuanyuan Liang; Sarah L Lake; John D Roache; Nathalie Hill-Kapturczak
Journal:  Drug Alcohol Depend       Date:  2014-12-31       Impact factor: 4.492

4.  Pain-related anxiety, sex, and co-use of alcohol and prescription opioids among adults with chronic low back pain.

Authors:  Lisa R LaRowe; Jessica M Powers; Lorra Garey; Andrew H Rogers; Michael J Zvolensky; Joseph W Ditre
Journal:  Drug Alcohol Depend       Date:  2020-07-10       Impact factor: 4.492

5.  Prevalence and impact of comorbid chronic pain and cigarette smoking among people living with HIV.

Authors:  Lisa R LaRowe; John D Cleveland; Dustin M Long; Shadi Nahvi; Edward R Cachay; Katerina A Christopoulos; Heidi M Crane; Karen Cropsey; Sonia Napravnik; Conall O'Cleirigh; Jessica S Merlin; Joseph W Ditre
Journal:  AIDS Care       Date:  2021-02-17

Review 6.  Current Understanding of the Neurobiology of Agitation.

Authors:  Christopher W T Miller; Vedrana Hodzic; Eric Weintraub
Journal:  West J Emerg Med       Date:  2020-07-02

7.  Policy change to improve pathology turnaround time and reduce costs--possible to do both?

Authors:  Goce Dimeski; Breeann Silvester; Jacobus Ungerer; Leslie Johnson; Jennifer H Martin
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.